All Other Countries was Cytosorbents’s largest region in fiscal 2025, bringing in $25.06M of $37.06M (68%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| All Other Countries | $15.82M | $18.05M | $22.39M | $25.06M | |||||
| Germany | $12.57M | $12.96M | $13.05M | $11.75M | |||||
| United States | $6.30M | $66.77K | $151.00K | $249.00K | |||||
| Total | $34.69M | $31.08M | $35.60M | $37.06M |
Cytosorbents brought in $37.06M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 4.1% from $35.60M in fiscal 2024. All Other Countries was the largest at $25.06M (67.6%), ahead of Germany at $11.75M (31.7%) and United States at $249.00K (0.7%).
Compared with fiscal 2024, All Other Countries grew 11.9% to $25.06M, while Germany fell 10.0% to $11.75M. From fiscal 2022 to 2025, combined revenue from these regions grew from $34.69M to $37.06M, a compound annual growth rate of 2.2%. All Other Countries' share of the total rose from 45.6% to 67.6%.
Direct was Cytosorbents’s largest revenue line in fiscal 2025, bringing in $20.60M of $37.06M (56%).
| Customer | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Direct | $18.06M | $18.99M | $20.78M | $20.60M | |||||
| Distributors/Strategic Partners | $11.30M | $12.10M | $14.81M | $16.46M | |||||
| United States Government Agencies | $5.33M | — | — | — | |||||
| Total | $34.69M | $31.08M | $35.60M | $37.06M |
Cytosorbents brought in $37.06M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 4.1% from $35.60M in fiscal 2024. Direct was the largest at $20.60M (55.6%), ahead of Distributors/Strategic Partners at $16.46M (44.4%).
Compared with fiscal 2024, Distributors/Strategic Partners grew 11.1% to $16.46M, while Direct fell 0.9% to $20.60M.
Cytosorbents stopped reporting United States Government Agencies as a separate revenue line after fiscal 2022, when it brought in $5.33M.
Cytosorbents (CTSO) reports its revenue by geography and by customer. In fiscal 2025, All Other Countries was its largest region, bringing in $25.06M (67.6% of the total), followed by Germany at $11.75M (31.7%).
All Other Countries was Cytosorbents' largest region in fiscal 2025, bringing in $25.06M, or 67.6% of the $37.06M total across its three regions.
Direct was Cytosorbents' largest revenue line in fiscal 2025, bringing in $20.60M, or 55.6% of the $37.06M total across its two revenue lines.
All Other Countries grew faster than Germany in fiscal 2025, up 11.9% from $22.39M to $25.06M. Germany fell 10.0% to $11.75M.
Every figure comes from Cytosorbents' annual financial filings, as reported. Each line keeps the name Cytosorbents gives it, and years follow its fiscal calendar.
Cytosorbents' revenue by geography goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.